Acceptability and Feasibility of a Pre-Exposure Prophylaxis (PrEP) Trial With Young Men Who Have Sex With Men (YMSM).
Phase of Trial: Phase II
Latest Information Update: 20 Apr 2017
At a glance
- Drugs Emtricitabine (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 05 Dec 2011 Actual patient number is 79 according to ClinicalTrials.gov.
- 05 Dec 2011 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.
- 05 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.